N4 Pharma PLC (N4P) — Financial Flexibility Index
N4 Pharma PLC (N4P) has a Financial Flexibility Index of -5.67x as of June 2025. Free cash flow of GBX-444.36K (operating CF GBX-444.37K minus capex GBX3.00) represents -6% of total liabilities (GBX78.37K). Check how aggressively does N4 Pharma PLC reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
N4 Pharma PLC Financial Flexibility Index (1991–2024)
Historical Financial Flexibility Index trend for N4 Pharma PLC across 34 annual periods. For the full cash flow conversion analysis, see how efficiently does N4 Pharma PLC generate cash.
Annual Financial Flexibility Index for N4 Pharma PLC (1991–2024)
Year-by-year free cash flow to debt coverage for N4 Pharma PLC. Explore N4 Pharma PLC (N4P) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -7.81x | GBX-971.50K | GBX-971.50K | GBX124.37K | ▲ +47.2% |
| 2023 | -14.79x | GBX-1.21 Million | GBX-1.21 Million | GBX81.73K | ▼ -39.1% |
| 2022 | -10.63x | GBX-828.26K | GBX-828.26K | GBX77.89K | ▼ -27.6% |
| 2021 | -8.33x | GBX-1.77 Million | GBX-1.77 Million | GBX212.73K | ▼ -2.1% |
| 2020 | -8.16x | GBX-1.38 Million | GBX-1.38 Million | GBX169.08K | ▲ +21.4% |
| 2019 | -10.38x | GBX-806.00K | GBX-806.00K | GBX77.68K | ▼ -46.7% |
| 2018 | -7.07x | GBX-1.34 Million | GBX-1.34 Million | GBX190.12K | ▼ -33.3% |
| 2017 | -5.31x | GBX-950.80K | GBX-950.80K | GBX179.22K | ▼ -8.6% |
| 2016 | -4.88x | GBX-376.00K | GBX-376.00K | GBX77.00K | ▲ +90.4% |
| 2015 | -50.71x | GBX-862.00K | GBX-862.00K | GBX17.00K | ▼ -11935.2% |
| 2014 | -0.42x | GBX-340.00K | GBX-340.00K | GBX807.00K | ▼ -394.6% |
| 2013 | 0.14x | GBX129.00K | GBX-87.00K | GBX902.00K | ▲ +309.1% |
| 2012 | -0.07x | GBX-85.00K | GBX-324.00K | GBX1.24 Million | ▼ -104.3% |
| 2011 | 1.57x | GBX2.31 Million | GBX996.00K | GBX1.47 Million | ▲ +127.0% |
| 2010 | 0.69x | GBX718.00K | GBX249.00K | GBX1.04 Million | ▼ -52.2% |
| 2009 | 1.45x | GBX1.68 Million | GBX755.00K | GBX1.16 Million | ▲ +97.0% |
| 2008 | 0.74x | GBX408.00K | GBX-184.00K | GBX554.00K | ▲ +131.0% |
| 2007 | 0.32x | GBX169.00K | GBX160.00K | GBX530.00K | ▲ +505.8% |
| 2006 | -0.08x | GBX-40.00K | GBX-67.00K | GBX509.00K | ▼ -189.6% |
| 2005 | -0.03x | GBX-105.00K | GBX-113.00K | GBX3.87 Million | ▼ -154.4% |
| 2004 | 0.05x | GBX203.00K | GBX140.00K | GBX4.07 Million | ▲ +8.9% |
| 2003 | 0.05x | GBX216.00K | GBX85.00K | GBX4.71 Million | ▲ +130.1% |
| 2002 | -0.15x | GBX-738.00K | GBX-739.00K | GBX4.85 Million | ▼ -447.4% |
| 2001 | 0.04x | GBX228.00K | GBX210.00K | GBX5.21 Million | ▲ +254.2% |
| 2000 | -0.03x | GBX-228.00K | GBX-380.00K | GBX8.03 Million | ▼ -155.6% |
| 1999 | -0.01x | GBX-97.00K | GBX-171.00K | GBX8.73 Million | ▲ +95.8% |
| 1998 | -0.26x | GBX-2.66 Million | GBX-2.72 Million | GBX10.10 Million | ▼ -541.7% |
| 1997 | -0.04x | GBX-1.07 Million | GBX-2.66 Million | GBX26.17 Million | ▼ -117.0% |
| 1996 | 0.24x | GBX5.69 Million | GBX2.02 Million | GBX23.55 Million | ▲ +48.9% |
| 1995 | 0.16x | GBX4.09 Million | GBX163.00K | GBX25.21 Million | ▼ -49.6% |
| 1994 | 0.32x | GBX6.07 Million | GBX3.34 Million | GBX18.88 Million | ▲ +244.2% |
| 1993 | 0.09x | GBX1.13 Million | GBX310.00K | GBX12.14 Million | ▼ -49.2% |
| 1992 | 0.18x | GBX3.35 Million | GBX2.72 Million | GBX18.22 Million | ▲ +306.8% |
| 1991 | -0.09x | GBX-1.78 Million | GBX-2.42 Million | GBX20.05 Million | — |